Cargando…
Prognostic gene expression profiling in melanoma: necessary steps to incorporate into clinical practice
Prognostic gene expression profiling (GEP) tests for cutaneous melanoma (CM) are not recommended in current guidelines outside of a clinical trial. However, their use is becoming more prevalent and some practitioners are using GEP tests to guide patient management. Thus, there is an urgent need to b...
Autores principales: | Grossman, Douglas, Kim, Caroline C, Hartman, Rebecca I, Berry, Elizabeth, Nelson, Kelly C, Okwundu, Nwanneka, Curiel-Lewandrowski, Clara, Leachman, Sancy A, Swetter, Susan M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920745/ https://www.ncbi.nlm.nih.gov/pubmed/31871621 http://dx.doi.org/10.2217/mmt-2019-0016 |
Ejemplares similares
-
The dark side of immunotherapy
por: Okwundu, Nwanneka, et al.
Publicado: (2021) -
From Melanocyte to Malignant Metastatic Melanoma
por: Manga, Prashiela, et al.
Publicado: (2010) -
Melanoma toolkit for early detection for primary care providers: A pilot study
por: Orfaly, Victoria E., et al.
Publicado: (2021) -
Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy
por: Johnson, Mariah M, et al.
Publicado: (2017) -
Selenium for the Prevention of Cutaneous Melanoma
por: Cassidy, Pamela B., et al.
Publicado: (2013)